Top Globe News – Lifestyle
Author:
Holliday Communications, Inc.
U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder
April 29, 2026